Nasopharyngeal Carcinoma at the Virology Precision Oncology Nexus: Decoding Molecular Alterations for Early Intervention and Therapeutic Innovation
Biomolecules · 2026
DOI: 10.3390/biom16020256 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von Na Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Cancer Invasion of Chinese Ministry of Education, Xiangya Hospital, Central South University, Changsha 410078, C…. Hauptthemen laut MEDLINE: Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections, Precision Medicine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hunan Provincial Natural Science Foundation of China, Hunan Provincial Postgraduate Research and Innovation Project.
Abstract (Originalsprache)
Nasopharyngeal carcinoma (NPC) represents an Epstein–Barr virus (EBV)-associated malignancy showing elevated incidence in East and Southeast Asia. Early detection remains vital, as molecular abnormalities precede visible histological changes during tumor development. This review summarizes recent progress in decoding NPC’s molecular profile, including genetic mutations, epigenetic alterations, non-coding RNA networks and proteomic alterations. Importantly, these molecular discoveries are increasingly informing clinical approaches to disease management. Modern diagnostic integration of histopathology, EBV biomarkers and advanced imaging has improved detection, yet locoregional recurrence and distant metastasis remain major causes of mortality. Immunotherapy shows promising efficacy in recurrent/metastatic NPC, underscoring the potential of molecular insights to guide therapeutic innovation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Carcinogenesis and Cancer Invasion of Chinese Ministry of Education, Xiangya Hospital, Central South University, Changsha 410078, China.
- Key Laboratory of Carcinogenesis of National Health Commission, Cancer Research Institute, Xiangya School of Basic Medical Sciences, Central South University, Changsha 410078, China.
- Molecular Imaging Research Center, Central South University, Changsha 410078, China.
- Department of Pathology, National Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Central South University, Changsha 410078, China.
Förderung
- National Natural Science Foundation of China
- Hunan Provincial Natural Science Foundation of China
- Hunan Provincial Postgraduate Research and Innovation Project
- Independent Exploration and Innovation Project for Postgraduate Students at Central South University
Zitieren
APA
Liu, N., Meng, B., Li, Y., Tang, M., Cao, Y., Shang, L., & Shi, F. (2026). Nasopharyngeal Carcinoma at the Virology Precision Oncology Nexus: Decoding Molecular Alterations for Early Intervention and Therapeutic Innovation. Biomolecules. https://doi.org/10.3390/biom16020256
Vancouver
Liu N, Meng B, Li Y, Tang M, Cao Y, Shang L, et al. Nasopharyngeal Carcinoma at the Virology Precision Oncology Nexus: Decoding Molecular Alterations for Early Intervention and Therapeutic Innovation. Biomolecules. 2026. doi:10.3390/biom16020256
BibTeX
@article{Liu2026,
author = {Liu, Na and Meng, Bin and Li, Yueshuo and Tang, Min and Cao, Ya and Shang, Li and Shi, Feng},
title = {Nasopharyngeal Carcinoma at the Virology Precision Oncology Nexus: Decoding Molecular Alterations for Early Intervention and Therapeutic Innovation},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16020256}
}
EUVIMED